PL417551A1 - Application of insulin for treatment of a diabetic foot in the form of direct injection into the bad foot - Google Patents
Application of insulin for treatment of a diabetic foot in the form of direct injection into the bad footInfo
- Publication number
- PL417551A1 PL417551A1 PL417551A PL41755116A PL417551A1 PL 417551 A1 PL417551 A1 PL 417551A1 PL 417551 A PL417551 A PL 417551A PL 41755116 A PL41755116 A PL 41755116A PL 417551 A1 PL417551 A1 PL 417551A1
- Authority
- PL
- Poland
- Prior art keywords
- foot
- insulin
- treatment
- application
- direct injection
- Prior art date
Links
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 title abstract 4
- 208000008960 Diabetic foot Diseases 0.000 title abstract 2
- 102000004877 Insulin Human genes 0.000 title abstract 2
- 108090001061 Insulin Proteins 0.000 title abstract 2
- 238000002347 injection Methods 0.000 title abstract 2
- 239000007924 injection Substances 0.000 title abstract 2
- 229940125396 insulin Drugs 0.000 title abstract 2
- 230000003902 lesion Effects 0.000 abstract 1
Landscapes
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
Przedmiotem zastosowania jest stosowanie insuliny do leczenia zmian chorobowych na stopie cukrzycowej poprzez iniekcje w chorą stopę.The subject of the application is the use of insulin for the treatment of diabetic foot lesions by injection into a sick foot.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PL417551A PL231417B1 (en) | 2016-06-13 | 2016-06-13 | Application of insulin for treatment of a diabetic foot in the form of direct injection into the bad foot |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PL417551A PL231417B1 (en) | 2016-06-13 | 2016-06-13 | Application of insulin for treatment of a diabetic foot in the form of direct injection into the bad foot |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| PL417551A1 true PL417551A1 (en) | 2017-12-18 |
| PL231417B1 PL231417B1 (en) | 2019-02-28 |
Family
ID=60655783
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL417551A PL231417B1 (en) | 2016-06-13 | 2016-06-13 | Application of insulin for treatment of a diabetic foot in the form of direct injection into the bad foot |
Country Status (1)
| Country | Link |
|---|---|
| PL (1) | PL231417B1 (en) |
-
2016
- 2016-06-13 PL PL417551A patent/PL231417B1/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| PL231417B1 (en) | 2019-02-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ECSP24031979A (en) | THERAPEUTIC ACTIVE COMPOUNDS AND THEIR METHODS OF USE | |
| CL2019000575A1 (en) | Amylin analogs. | |
| EA201790398A1 (en) | METHODS OF TREATING LIVER DISEASES | |
| TWD161529S (en) | Therapeutic lamp | |
| CR20160104A (en) | CATHETER CONNECTION STABILIZATION DEVICE AND SAME USE PROCEDURES | |
| TWD174972S (en) | Portion of a shoe midsole (2) | |
| EA201500934A1 (en) | CARDIO AND NEPHROPROTECTIVE ANTI-DIABETIC THERAPY | |
| EA201690754A1 (en) | APPLICATION OF PCSK9 INHIBITOR FOR THE TREATMENT OF HYPERLIPIDEMIA | |
| AR098738A1 (en) | ANALOGS OF THE EXENDINE PEPTIDE-4 NOT CLOSED | |
| UY35548A (en) | THERAPEUTIC PEPTIDES FOR THE TREATMENT OF METABOLIC DISORDERS. | |
| BR112018003297A2 (en) | female pad with barrier clamps | |
| CL2019001996A1 (en) | Therapeutic uses of an insect powder. | |
| MX2015012444A (en) | METHODS OF DIAGNOSIS, SELECTION AND TREATMENT OF DISEASES AND AFFECTIONS CAUSED BY OR ASSOCIATED WITH METHANOGENS. | |
| MX2017014396A (en) | Treatment for multiple myeloma (mm). | |
| MX2016013245A (en) | S1p modulator immediate release dosage regimen. | |
| PE20160012A1 (en) | TREATMENT OF MYOPATHIC AND NEUROGENERATIVE DISEASES BY PROTEIN ADMINISTRATION BY PARENTERAL ADMINISTRATION | |
| NI201700024A (en) | ANAMORELIN-BASED MEDICAL TREATMENTS | |
| MX2017009294A (en) | Treatment of pediatric type 2 diabetes mellitus patients with lixisenatide. | |
| BR112015031417A8 (en) | pharmaceutical dosage form, pharmaceutical composition, methods for treating a patient in need of cysteamine and for preparing a dosage form | |
| TWD173150S (en) | One design of a shoe upper | |
| EA201691860A1 (en) | PEPTIDE MEDICINE AS A DRY POWDER | |
| CR20140473A (en) | PIRAZOL COMPOUNDS AS SGLT1 INHIBITORS | |
| EA201792056A1 (en) | TREATMENT OF PATIENTS WITH DIABETES MELLITUS TYPE 2 | |
| MX2015012455A (en) | Method for the treatment of fatty liver disease. | |
| EA201500765A1 (en) | METHODS OF TREATING CARDIOVASCULAR DISEASES |